Maven Clinic’s Virtual Care Clinic Goes In Network with 475 Plans
Maven Clinic is making its virtual care services accessible through more than 475 health plans nationwide.
Maven Clinic is making its virtual care services accessible through more than 475 health plans nationwide.
In this episode, we’re joined by Dr. Rani Aravamudhan, senior medical director of Artemis at Nomi Health. We discuss Nomi Health’s new research on endometriosis.
Pregnancy and NICU admissions are among the most complex areas in healthcare. A new report from ProgenyHealth highlights how the company can work with Medicaid and commercial health plans to uncover insights and hidden risks critical to improving maternal and infant care and reducing costs.
Willow Innovations acquired Swehl and Momtech to expand its maternal health offerings beyond breast pumps.
Women’s health experts had mixed reactions to the Trump administration's executive order on women's health.
Perimenopausal anxiety isn't simply in our patients' heads. It's often the result of complex physiologic changes involving hormones, sleep, metabolism, and the nervous system.
BTK inhibitor has become an important treatment option for certain B-cell malignancies.
In this episode, we’re joined by Claire Love, deals strategy principal at PwC. We discuss PwC’s recent report showing the opportunities in the fertility and reproductive health market.
While SUD affects people across all demographics, a growing body of research and clinical experience makes one point clear: gender meaningfully influences how substance use develops, how it is experienced, and what supports effective treatment.
Early intervention based on accurate diagnosis of both metabolic risk factors and acute cardiac events could help make the difference between life and death for women.
Women’s health startups should plan for reimbursement early, as limited research and evidence can make securing coverage difficult, a new report explains.
In this episode, we’re joined by Cheryl Larson, president and CEO of the Midwest Business Group on Health, for our first in-person recording at MedCity News’ recent Bullseye event.
Juno Bio’s funding was supported by Ada Ventures, Artesian, Entrepreneur First and Illumina Accelerator.
For someone already managing chronic disease, menopause can disrupt stability and complicate treatment plans in ways that aren’t always immediately visible but show up over time in outcomes and utilization.
Testosterone is not just a “male hormone.” Women need it too. And pretending otherwise has left countless women struggling through midlife while being told everything looks “normal.”
While the Pap identifies the cell changes, the HPV test determines the root cause before those changes even happen. Both tests have saved lives. But they are not interchangeable, and treating them as such puts the patient at risk.